April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
NY Prostate Cancer Conference - A. Stephenson - Session 4: Predicting clinical and biochemical endpoints after surgery
1. Predicting Clinical and Biochemical Endpoints after Radical Prostatectomy Andrew J. Stephenson, MD FRCSC FACS Director, Urologic Oncology Glickman Urological and Kidney Institute Cleveland Clinic
2.
3.
4. Postoperative Nomogram Kattan et al. J Clin Oncol 1999; Graefen et al. J Clin Oncol 2002; Bianco et al. J Urol 2003 Single surgeon, 996 pts, open RP, 1983-1997, BCR Endpoint: PSA 0.4 ng/mL and rising Bootstrapped c-index: 0.88 Model predictions remarkably robust when applied to diverse external validation populations C-index 0.80-0.83
5.
6.
7.
8.
9.
10.
11. Prostate Cancer-Specific Survival: Gleason Score Analysis Eggener et al. J Urol 2011 Gleason 6 Glsn 3+4 Glsn 4+3 Glsn 8-10 Age < 60 Age 60-69 Age > 69
12. Prostate Cancer-Specific Survival: Pathological Stage Eggener et al. J Urol 2011 Organ- Confined EPE SVI LNI Age < 60 Age 60-69 Age > 69